Search
Foslevcromakalim
go.drugbank.com/drugs/DB21500ExperimentalThe usage of the INN stem '-kalim' in the name indicates that Foslevcromakalim is a potassium channel activator, antihypertensive. Foslevcromakalim has a monoisotopic molecular weight of 366.1 Da.
Izuforant
go.drugbank.com/drugs/DB21571ExperimentalThe usage of the INN stem '-forant' in the name indicates that Izuforant is a histamine H4 receptor antagonist. Izuforant has a monoisotopic molecular weight of 333.03 Da.
Inixaciclib
go.drugbank.com/drugs/DB21584ExperimentalThe usage of the INN stem '-ciclib' in the name indicates that Inixaciclib is a cyclin dependant kinase inhibitor. Inixaciclib has a monoisotopic molecular weight of 480.24 Da.
Culmerciclib
go.drugbank.com/drugs/DB21600InvestigationalThe usage of the INN stem '-ciclib' in the name indicates that Culmerciclib is a cyclin dependant kinase inhibitor. Culmerciclib has a monoisotopic molecular weight of 446.23 Da.
Monzosertib
go.drugbank.com/drugs/DB21619InvestigationalThe usage of the INN stem '-sertib' in the name indicates that Monzosertib is a serine/threonine kinase inhibitor. Monzosertib has a monoisotopic molecular weight of 465.16 Da.
Votoplam
go.drugbank.com/drugs/DB21645InvestigationalThe usage of the INN stem '-plam' in the name indicates that Votoplam is a SMN2 gene splicing modulator. Votoplam has a monoisotopic molecular weight of 419.22 Da.
Potrasertib
go.drugbank.com/drugs/DB21682ExperimentalThe usage of the INN stem '-sertib' in the name indicates that Potrasertib is a serine/threonine kinase inhibitor. Potrasertib has a monoisotopic molecular weight of 564.19 Da.
Tigemocoxib
go.drugbank.com/drugs/DB21699ExperimentalThe usage of the INN stem '-coxib' in the name indicates that Tigemocoxib is a selective cyclo-oxygenase inhibitor. Tigemocoxib has a monoisotopic molecular weight of 334.06 Da.
Peripheral T-Cell Lymphoma (PTCL)
go.drugbank.com/conditions/DBCOND0079798Drugs: Brentuximab vedotinSynonyms: Peripheral T-cell lymphoma, NOS, Peripheral T-cell lymphoma unspecified NOSVeligrotug
go.drugbank.com/drugs/DB18976Approved[L63798] Although its precise mechanism in thyroid eye disease has not been fully characterized, IGF-1R blockade reduces the proptosis and diplopia that define the condition.